PTCT stock forecast
Our latest prediction for PTC Therapeutics Inc's stock price was made on the March 30, 2023 when the stock price was at 48.86$.
In the short term (2weeks), PTCT's stock price should underperform the market by -2.18%. During that period the price should oscillate between -6.05% and +4.45%.
In the medium term (3months), PTCT's stock price should underperform the market by -15.70%. During that period the price should oscillate between -24.82% and +15.32%.
Get email alertsCreate a solid portfolio with PTCT
About PTC Therapeutics Inc
ptc is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. while ptc’s discovery programs are directed at targets in multiple therapeutic areas, ptc is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. ptc’s internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. for more information on the company, please visit our website www.ptcbio.com.
At the moment the company generates 35M USD in revenues.
On its last earning announcement, the company reported a loss of -7.79$ per share.
The book value per share is 5.33$
Three months stock forecastMarch 30, 2023
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
35M | 1972.89% | -447M | -1263.15% | -559M | -7.79 | - | - | 73M | 5.33 | - | - | - |